Letter: The Potential Risk of HBV Reactivation in Patients With Resolved HBV Infection During Direct-Acting Antiviral Therapy - Authors' Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14259
Full Text
Open PDFAbstract
Available in full text
Date
September 7, 2017
Authors
Publisher
Wiley